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Abstract. 
 
The biogenesis of secretory granules embod-
ies several morphological and biochemical changes. In 
particular, in neuroendocrine cells maturation of secre-
tory granules is characterized by an increase in size 
which has been proposed to reflect homotypic fusion of 
immature secretory granules (ISGs). Here we describe 
an assay that provides the first biochemical evidence 
for such a fusion event and allows us to analyze its regu-
lation. The assay reconstitutes homotypic fusion be-
tween one population of ISGs containing a [
 
35
 
S]sulfate-
labeled substrate, secretogranin II (SgII), and a second 
population containing the prohormone convertase PC2. 
Both substrate and enzyme are targeted exclusively to 
ISGs. Fusion is measured by quantification of a cleav-
age product of SgII produced by PC2. With this assay 
we show that fusion only occurs between ISGs and not 
between ISGs and MSGs, is temperature dependent, 
and requires ATP and GTP and cytosolic proteins. NSF 
(
 
N
 
-ethylmaleimideÐsensitive fusion protein) is amongst 
the cytosolic proteins required, whereas we could not 
detect a requirement for p97. The ability to reconstitute 
ISG fusion in a cell-free assay is an important advance 
towards the identification of molecules involved in the 
maturation of secretory granules and will increase our 
understanding of this process.
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S
 
ecretory
 
 granules are specialized exocytic vesicles
responsible for the controlled release of bioactive
molecules, such as hormones. During the lifetime of
the secretory granule, from formation to consumption, a
series of regulatory events control its composition and
size. Control of these events is crucial for the fidelity of
regulated secretion. Secretory granules originate from the
TGN with a selected subset of lumenal and membrane
proteins: this protein selection during formation is pre-
sumably controlled by proteins both within the lumen of
the TGN and in the cytoplasm (Tooze, 1998). Cargo selec-
tion may be via receptorÐligand type interactions. For ex-
ample, carboxypeptidase E recognizes a motif present in
several prohormones and has been implicated as a general
cargo receptor (Cool et al., 1997) although this is currently
the subject of intense debate (Irminger et al., 1997; Thiele
et al., 1997). To date, no cytoplasmic coat proteins have
been implicated in the selection of cargo receptors or
secretory granule membrane proteins. Patches of clathrin
have been detected on the TGN membrane in the region
of the budding immature secretory granule (ISG)
 
1
 
 al-
though there is no evidence that clathrin is involved in for-
mation of secretory granules (for review see Urb et al.,
1997
 
b
 
). Formation of ISGs is regulated by heterotrimeric
G proteins (Barr et al., 1991) and proteins required for
lipid metabolism (Chen et al., 1997; Ohashi et al., 1995) al-
though how these are involved in protein sorting during
ISG formation is not known.
Additional proteins and machinery will undoubtedly be
identified and found to be involved in secretory granule
biogenesis at the TGN. However, it is already well estab-
lished that the selection mechanisms operative in the TGN
alone are not sufficient to produce a mature secretory
granule (MSG). Isolation of ISGs (Tooze et al., 1991) con-
firmed the previous morphological data (Salpeter and Far-
quhar, 1981) showing that ISGs are smaller than MSGs.
Subsequently, proteins were found in ISGs that are not
present in MSGs, such as furin (Ditti et al., 1997), lysoso-
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1. 
 
Abbreviations used in this paper: 
 
CCV, clathrin-coated vesicle; ISG, im-
mature secretory granules; MP, membrane pellet; MPR, mannose-6-phos-
phate receptor; MSG, mature secretory granule; NEM, 
 
N
 
-ethylmaleimide;
NSF; 
 
N
 
-ethylmalemideÐsensitive fusion protein; PC2, prohormone con-
vertase 2; PNS, postnuclear supernatant; SgII, secretogranin II; SNAP,
soluble NSF attachment protein; SNARE, SNAP receptor; STI, soybean
trypsin inhibitor; t-SNARE, target SNARE; v-SNARE, vesicle SNARE.
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mal enzymes (Kuliawat et al., 1997) and the mannose-6-phos-
phate receptor (Klumperman, 1998). In addition, the lu-
menal pH of the ISG is 
 
z
 
6.3 whereas the lumenal pH of
the MSG is 
 
z
 
pH 5.5 (Orci et al., 1994; Urb et al., 1997
 
a
 
).
The differences in size and content between ISGs and
MSGs have led to the proposal that the nascent ISG,
which buds from the TGN is an intermediate stage in
secretory granule biogenesis (Tooze et al., 1991). Matura-
tion of the intermediate ISG to an MSG would require
both fusion and budding events. Fusion events between
ISGs would result in an increase in the size of ISGs to that
of MSGs, whereas budding of vesicles from the ISG would
allow removal of nonessential proteins and excess mem-
brane. The coordinated action of budding and fusion
would exert a tight control on both the composition and
quantal size of the released secretory granule content
upon stimulation. This hypothesis is supported by mor-
phological data demonstrating that MSGs in endocrine
cells have a defined size depending on the cell type. For
example, within the anterior pituitary gland the mam-
motrophs have MSGs 350 
 
m
 
m in diameter, whereas the go-
nadotrophs have MSGs 200 
 
m
 
m in diameter (Smith and
Farquhar, 1966). The size differences may be related to
the biophysical properties of the major content protein
and the structure of the dense core, although the mecha-
nisms that underlie this phenomenon are not known (Bur-
gess and Kelly, 1987).
We are interested in understanding the mechanisms that
control secretory granule composition and size, and deter-
mining if these might involve fusion and budding from the
ISG. In one approach we have developed a cell-free assay
that reconstitutes fusion between ISGs. The assay is based
on the interaction of an endopeptidase with its substrate,
both of which are specifically sorted into secretory gran-
ules. We have designed the assay so that the substrate,
which is labeled by radioactive sulfate on tyrosine resi-
dues, is present in one ISG population, whereas the en-
zyme is present in another population of ISGs. Upon fu-
sion of the two ISG populations the enzyme will cleave the
labeled substrate into discrete fragments. Fusion is mea-
sured by immunoprecipitation with a specific antibody
which only recognizes one of these fragments and not the
intact substrate.
With this assay we have investigated the requirements
for cytosolic components involved in ISG fusion. In partic-
ular, we have asked if either one of the two well-character-
ized 
 
N
 
-ethylmaleimide (NEM)Ðsensitive proteins, NEM
sensitive fusion protein (NSF), or p97 are involved in ISG
fusion. NSF, first identified by Rothman and colleagues
(Block et al., 1988) is involved in vesicular transport along
the secretory pathway, fusion events in the endocytic path-
way, and regulated exocytosis (for review see Whiteheart
and Kubalek, 1995; Woodman, 1997). p97, or its yeast ho-
mologue cdc48p, was shown to be necessary for homotypic
fusion events involved in organelle maintenance (Acharya
et al., 1995
 
a
 
; Latterich et al., 1995; Rabouille et al., 1995
 
a
 
).
Both are ATPases which bind to membranes via attach-
ment proteins, soluble NSF attachment proteins (SNAPs)
(Whiteheart et al., 1993) in the case of NSF (Clary et al.,
1990; Weidman et al., 1989) and p47 for p97 (Kondo et al.,
1997; Rabouille, 1998). NSF and SNAPs interact with de-
tergent-solubilized soluble NSF attachment protein recep-
tors (SNAREs) to form a 20 S particle (Sollner et al.,
1993). Over 20 SNAREs have been identified (for review
see Advani et al., 1998; Bock and Scheller, 1997) which are
classified into two families, v-SNAREs found on the vesi-
cle and t-SNAREs found on the target membrane. The
structural similarity of the SNAREs, combined with their
restricted localization is the basis of the current model for
vesicular transport through the secretory pathway (Roth-
man, 1994; for review see Gtte and von Mollard, 1998).
Recently, interaction of a v-SNARE with a t-SNARE has
been shown to be the minimal requirement for fusion of li-
posomes (Weber et al., 1998).
The interaction of p97 or cdc48p with membranes also
requires a SNARE protein, the t-SNARE syntaxin 5
(Rabouille, 1998), and Ufe1p (Patel, 1998), respectively. It
has recently been proposed that whereas heterotypic
fusion requires the pairing of cognate v- and t-SNAREs,
homotypic fusion can also proceed via the pairing of
t-SNAREs alone (Nichols et al., 1997) and may be in some
cases mediated by cdc48p or p97 (Patel, 1998; Rabouille,
1998, respectively).
Using the in vitro system we describe here we report
that fusion of ISGs can be reconstituted in a cell-free as-
say, and provide the first biochemical evidence that ISGÐ
ISG fusion can occur. This fusion requires ATP, GTP, and
elevated temperature plus cytosolic components. We have
found that NSF, but not p97, is required for homotypic
ISG fusion. Further understanding of the role of ISGÐISG
fusion during maturation, and how the generation of
MSGs may be controlled by ISG fusion will be greatly fa-
cilitated with this assay.
 
Materials and Methods
 
Materials and Reagents
 
Carrier-free [
 
35
 
S]sulfate as a disodium salt was supplied by Amersham
Pharmacia Biotech (Piscataway, NJ). Fine chemicals were supplied by
Sigma Chemical Co. (St. Louis, MO) or Boehringer Mannheim (Mann-
heim, Germany). PC12 cells (clone 251) were originally obtained from
H. Thoenen (Max Planck Institute, Martinsried, Germany) (Heumann et
al., 1983). PC12/PC2 cell lines stably expressing the endoprotease PC2
have been previously characterized (Ditti and Tooze, 1995). PC12 and
PC12/PC2 cells were grown in DME supplemented with 10% horse serum
and 5% fetal calf serum at 10% CO
 
2
 
.
 
Antibodies and Recombinant Proteins
 
Horseradish peroxidase (HRP)-conjugated anti-rabbit and anti-mouse
IgGs were supplied by Amersham (Little Chalfont, UK). Antibodies
raised against SgII (175 and 100) have been previously described (Ditti
et al., 1996). Anti-NSF antibody was provided by M. Tagaya (Tokyo Uni-
versity, Tokyo, Japan), antiÐ
 
a
 
-SNAP by T. Sllner (Sloan-Kettering, New
York, NY), purified p97 and his-tagged p47, anti-p97, and p47 by H.
Kondo (Imperial Cancer Research Fund [ICRF], London, UK). His-
tagged NSF and His-tagged 
 
a
 
-SNAP were a kind gift of G. Schiavo
(ICRF).
Antibodies specific for the free COOH terminus of p18 were raised
against the peptide (KEENSRENPF) from rat SgII (Gerdes et al., 1988).
Polyclonal antisera were obtained from rabbits (ab69), whereas the mono-
clonal antibody was developed from hybridomas using a standard proce-
dure (6B1). Both the polyclonal and monoclonal antibodies are specific
for the free COOH terminus of p18 as assessed by standard Western blot-
ting, immunoprecipitation, and immunofluorescence techniques using ly-
sates obtained from either PC12 cells or PC12/PC2 cells. Experiments
have been performed with either or both polyclonal antibody (ab69) and
monoclonal antibody (6B1). 
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Preparation of Postnuclear Supernatant, ISGs,
and MSGs
 
A postnuclear supernatant (PNS) was prepared in HB-PMSF (250 mM su-
crose, 10 mM Hepes-KOH, pH 7.2, 1 mM Mg[OAc]
 
2
 
, 1 mM EDTA, pH
7.2, with 0.5 mM PMSF) as described (Tooze and Huttner, 1990) and con-
tained 
 
z
 
10 mg/ml of protein as determined by Bio-Rad protein microas-
say (using bovine IgG as a standard; Hercules, CA). PC12 cells were la-
beled with [
 
35
 
S]sulfate and chased as previously described (Tooze and
Huttner, 1990) for the times specified in the figure legends.
ISGs and MSGs were prepared as described in Ditti et al. (1996). In
brief, 1.3 ml of PC12 or PC12/PC2 PNS was loaded on linear sucrose gra-
dients of 0.3Ð1.2 M sucrose in 10 mM Hepes-KOH, pH 7.2, and subjected
to velocity controlled centrifugation. Fractions from the top of the velocity
gradient containing ISGs and MSGs were pooled and subjected to equilib-
rium sucrose gradient centrifugation. Fractions of 1 ml were collected
from the top and fractions seven to nine were pooled for the ISGs whereas
fractions 10Ð12 were pooled for the MSGs. Aliquots were stored in liquid
nitrogen and used within 6 mo. All gradient preparations were routinely
checked using [
 
35
 
S]sulfate labeling to ensure that the preparations were
consistent and correct sorting of the soluble proteins was achieved (Tooze
and Huttner, 1990).
 
Preparation of PC12 Cytosol
 
PC12 cells (
 
z
 
10
 
7
 
Ð10
 
8
 
 cells) were homogenized in HB-PMSF and a PNS
was prepared as described above. The PNS was then subjected to centrifu-
gation for 30 min at 30,000 
 
g
 
av
 
, followed by a second centrifugation of the
supernatant at 100,000 
 
g
 
av
 
 for 90 min at 4
 
8
 
C. Cytosol was stored in liquid
nitrogen and used within 3 mo. The protein concentration of the PC12 cy-
tosol was determined using the Bio-Rad microassay and was typically be-
tween 8 and 13 mg/ml.
 
Preparation of Rat Liver Cytosol
 
Rat livers either from Wistar or Sprague-Dawley male or female rats were
used. The livers were washed, minced, and then homogenized either in FB
(20 mM Hepes-KOH, pH 7.4, 50 mM KOAc, 3 mM MgCl
 
2
 
, 1 mM DTT),
containing 250 mM sucrose or protease inhibitors (0.5 mM PMSF, 10.5 
 
m
 
M
leupeptin) and then centrifuged as described for the PC12 cell cytosol
above. Alternatively, cytosol was prepared as described (Rabouille et al.,
1995
 
b
 
) in 0.5 M sucrose, 0.1 M KPO
 
4
 
, pH 6.7, 5 mM MgCl
 
2
 
 and protease
inhibitors. After centrifugation both cytosol preparations were precipi-
tated with 40% ammonium sulfate, resuspended in FB containing 250 mM
sucrose and protease inhibitors, and either dialyzed overnight against FB
containing 250 mM sucrose or desalted into FB containing 250 mM su-
crose with a PD10 column (Bio-Rad). Aliquots were stored in liquid nitro-
gen and used within 3 mo. The protein concentration of these cytosols was
typically between 20 and 40 mg/ml.
 
Cell-free Assays for ISGÐISG Fusion and Processing
 
Reconstitution of ISG Fusion with a PNS. 
 
PC12 cells were pulse-labeled
with [
 
35
 
S]sulfate or pulse-labeled and chased, before being washed, har-
vested, and homogenized to prepare a PNS as described above. PC2-ISGs
were thawed rapidly at 37
 
8
 
C, diluted at 4
 
8
 
C with 2 vol of 10 mM Hepes-
KOH, pH 7.2, pelleted by centrifugation at 100,000 
 
g
 
av
 
 for 1 h. The pellets
were resuspended in HB-PMSF at 50-fold the concentration of the origi-
nal ISG pool. If not indicated otherwise, standard conditions were as fol-
lows: 100 
 
m
 
l of the PC12 PNS per condition were supplemented with 10
 
3
 
FB, ATP-regenerating system (see below), and 10 
 
m
 
l PC2-ISGs in a final
volume of 120Ð160 
 
m
 
l.
After incubation at 4
 
8 
 
or 37
 
8
 
C the samples were transferred to ice and
diluted with low pH buffer (50 mM MES, pH 5.5, in 0.3 M sucrose) to a fi-
nal volume of 800 
 
m
 
l. The samples were preincubated for 30 min on ice to
equilibrate the pH in the ISGs with the buffer and then transferred to
37
 
8
 
C to allow processing of SgII by PC2 to take place. After this process-
ing incubation, the samples were placed on ice and 200 
 
m
 
l of 5
 
3
 
 lysis
buffer (500 mM Tris-HCl, pH 7.5, 750 mM NaCl, 1.5% Triton X-100, 25 mM
EDTA for ab69, or 500 mM Tris-HCl, pH 7.5, 750 mM NaCl, 5% Triton
X-100, 0.5% SDS, 5% Na deoxycholate for 6B3) was added. The lysed
samples were precleared by a 5-min spin in an Eppendorf centrifuge
(Eindhoven, The Netherlands) and subjected to immunoprecipitation as
described below.
ATP-regenerating system (Davey et al., 1985) stock solutions con-
tained 100 mM ATP, pH 7, 800 mM creatine phosphate, and 3,200 U/ml
 
creatine phosphokinase that were mixed before use in equal volumes to
give a 30
 
3
 
 stock. ATP depletion was performed with 3.3 mM 
 
d
 
-glucose
and 25 U/ml hexokinase. AMP-PNP (final concentration 100 
 
m
 
M), GTP
(final concentration 300 
 
m
 
M), and GTP
 
g
 
S (final concentration 100 
 
m
 
M)
were made up as a 100
 
3
 
 stock solutions in H
 
2
 
O.
 
Immunoprecipitation and Quantitation of [
 
35
 
S]sulfate-labeled p18. 
 
For
standard immunoprecipitations from cell-free fusion assay incubations
polyclonal ab69 and protein AÐSepharose (Amersham Pharmacia Bio-
tech) or monoclonal 6B1 and protein GÐSepharose (Sigma Chemical Co.)
were used. The immunoprecipitates were washed with lysis buffer, eluted
from the beads by boiling in Laemmli sample buffer, and then analyzed by
SDS-PAGE using a modified Laemmli system (Lee and Huttner, 1983),
followed by fluorography with 1 M sodium salicylate for 30 min and expo-
sure to a preflashed Kodak XAR5 film (Eastman-Kodak, Rochester,
NY). The fluorographs were usually exposed to film for 3Ð5 d, except for
those obtained with material labeled as in Fig. 3 
 
a
 
 where exposures longer
than 2 wk were required. Quantitation of [
 
35
 
S]sulfate-labeled p18 was by
densitometry using the NIH Image package version 68k/1.58 (Bethesda,
MD). If not indicated otherwise, the PC2-independent signal was sub-
tracted from the signal obtained in the presence of PC2-ISGs.
 
Treatment of PC2-ISGs with Trypsin Before and After Fusion. 
 
PC2-ISGs
were incubated with trypsin (20 ng trypsin/
 
m
 
g ISG protein or 200 ng
trypsin/
 
m
 
g ISG protein) either with or without 25 
 
m
 
g of soybean trypsin in-
hibitor (STI) for 15 min at room temperature, placed on ice, and then
PMSF and STI were added. The ISGs were then pelleted for 1 h, 5 min at
100,000 
 
g
 
av
 
. Postfusion and postprocessing treatment with trypsin was per-
formed with a final concentration of 0.1 mg/ml trypsin (200 ng trypsin/
 
m
 
g
ISG protein) in the absence or presence of 0.3% Triton X-100 for 15 min
at 37
 
8
 
C. After digestion STI was added and the samples were solubilized
in Laemmli sample buffer.
 
Cell-free Assay Using a Membrane Pellet. 
 
To obtain a membrane pellet,
the PNS was layered on top of a 1 ml sucrose cushion (0.5 M sucrose in 10
mM Hepes-KOH, pH 7.2). The membranes were pelleted by centrifuga-
tion for 1 h, 5 min at 100,000 
 
g
 
av
 
 at 4
 
8
 
C. The supernatant was removed and
the membranes were resuspended in HB or cytosol to their original vol-
ume. An ATP-regenerating system, 10
 
3
 
 FB, and PC2-ISGs were added as
described for the standard cell-free assay using a PNS. GTP was included
when rat liver cytosol was used.
 
Cell-free Assay Using Sucrose Gradient Fractions. 
 
For the type of exper-
iment shown in Fig. 8, the PNS was first subjected to velocity controlled
sucrose centrifugation to separate the TGN and post-TGN vesicles. The
fractions from the top of the velocity gradient (fractions 2Ð4) were pooled,
diluted with 10 mM Hepes-KOH, pH 7.2, and subjected to centrifugation
as above. The membranes were then resuspended in cytosol or HB in a
volume corresponding to the volume of the PNS loaded and used as de-
scribed.
 
NEM Treatment of Cytosol and Membranes. 
 
NEM treatment of PNS or
cytosol was performed using freshly made 50 mM NEM stock solution in
dH
 
2
 
O added to a final concentration of 3 mM. The samples were mixed
immediately, incubated for 10 min on ice, and then quenched by addition
of 3.6 mM glutathione for 15 min on ice. The membranes were then pel-
leted through a sucrose cushion as described above while cytosol was used
without further treatment. Control samples were treated with glutathione
only.
 
Results
 
Experimental System to Reconstitute Fusion of ISGs
 
To study the molecular requirements for fusion of ISGs
we have developed an assay that allows reconstitution of
fusion in a cell-free extract. The assay is based on content
mixing after fusion of ISGs which allows an enzymeÐ
substrate interaction to occur. Prohormone convertases
cleave prohormones, and other regulated secretory pro-
teins containing a dibasic amino acid site, in a pH and
Ca
 
2
 
1
 
-dependent fashion (Steiner, 1991). PC2, a prohor-
mone convertase that preferentially cleaves dibasic amino
acid sites composed of lysine and arginine at a pH opti-
mum of 5.5 and at micromolar Ca
 
2
 
1
 
 concentrations (Ben-
nett et al., 1992) was used in this assay. As the substrate
for PC2, we have used secretogranin II (SgII), an abun- 
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dant resident secretory granule protein present in all neu-
roendocrine cells that contains nine potential dibasic
amino acid cleavage sites. SgII is sulfated on tyrosine by
tyrosylprotein sulfotransferase (TPST), an enzyme that is
localized to the TGN (Niehrs et al., 1992). Tyrosine sulfa-
tion has been frequently exploited to label proteins in the
TGN (for example see Tooze and Huttner, 1990; Carnell
and Moore, 1994; Itin, 1997). The processing of SgII by
PC2 has been studied in PC12 cells either stably trans-
fected with the cDNA encoding PC2 (PC12/PC2 cells; Dit-
ti and Tooze, 1995) or after infection with recombinant
vaccinia virus encoding PC2 (Laslop et al., 1998). In PC12/
PC2 cells, sulfated SgII exits from the TGN in secretory
granules and is cleaved by PC2 within the secretory gran-
ule into several fragments (Urb et al., 1997
 
a
 
). The sul-
fated fragments are derived from the NH
 
2
 
 terminus and
include p18, the end product of the PC2-catalyzed process-
ing reaction (Fig. 1 
 
a
 
).
A scheme of the assay is shown in Fig. 1 
 
b
 
. The acceptor
ISG fraction containing [
 
35
 
S] SgII is present in a PNS de-
rived from wild-type PC12 cells labeled with [
 
35
 
S]sulfate.
Since wild-type PC12 cells have no PC1 or PC2 enzymes,
SgII is present in an unprocessed form of 86 kD. The do-
nor is an enriched population of ISGs containing PC2
(PC2-ISGs) isolated by subcellular fractionation from un-
labeled PC12/PC2 cells (Ditti and Tooze, 1995). After
preparation of the fusion partners, the donor PC2 ISGs
are added to the acceptor PNS and incubated at either 4
 
8
 
or 37
 
8
 
C in the presence or absence of ATP. During this re-
action, referred to as the fusion reaction, the wild-type
ISGs fuse with the PC2-ISGs and the granule contents
mix. Next, the samples are diluted with a pH 5.5 buffer,
equilibrated at 4
 
8
 
C for 30 min, and then warmed to 37
 
8
 
C
for 45Ð90 min for the processing reaction. During this sec-
ond incubation the PC2 enzyme recognizes the dibasic
amino acid sites in the [
 
35
 
S]sulfate-labeled SgII and at pH
5.5, processes it into several fragments. The sulfated frag-
ments, including the processing end product p18, will then
accumulate in the hybrid ISGs. The processing reaction
ensures that the readout of this assay (i.e., processing of
SgII) is independent of the conditions used during the fu-
sion reaction. Lysis buffer is then added to the sample and
the end product of processing p18 is immunoprecipitated
with p18-specific antibodies.
 
Characterization of the Antibody Specific for the 
Fusion Product p18
 
To detect the [
 
35
 
S]sulfate-labeled SgII fragment (p18) gen-
erated by PC2 as a result of fusion we developed antibod-
ies that only recognize the free COOH terminus of p18.
Polyclonal antibody ab69 and monoclonal antibody 6B3
were characterized using immunoblotting and immuno-
precipitation techniques with extracts obtained from both
PC12/PC2 cells and PC12 cells. As previously shown,
[
 
35
 
S]sulfate-labeled SgII in PC12/PC2 cells is processed by
PC2 into several smaller molecular weight fragments in-
cluding p18 (Ditti and Tooze, 1995). All the sulfated pro-
cessing products as well as the full length SgII can be visu-
alized by immunoprecipitation with ab100 (Fig. 1 
 
c
 
, lane 
 
1
 
)
whereas ab175 recognizes only the intact SgII (Fig. 1 
 
c
 
,
lane 
 
2
 
). In addition to the full-length protein (p86), the sul-
fated fragments of SgII immunoprecipitated are 38, 24,
and 18 kD. Of these fragments only the 18-kD protein was
immunoprecipitated with ab69 or 6B3 from [
 
35
 
S]sulfate-
labeled extracts from PC12/PC2 cells (Fig. 1 
 
c
 
, lane 
 
3
 
).
Immunoprecipitation with ab69 and 6B3 of extracts from
unlabeled or [
 
35
 
S]sulfate-labeled wild-type PC12 cells con-
Figure 1. Experimental de-
sign of the ISG fusion assay.
(a) Processing of SgII by
PC2. The major sulfated pro-
cessing products of SgII (38,
24, and 18 kD) are illustrated
with the full-length protein
(86 kD). Solid boxes, se-
quences recognized by the
antibodies used in this study;
arrowheads, the di-basic
amino acid sites used by PC2;
solid dots, the tyrosine resi-
due which is sulfated by
TPST. (b) Scheme of ISGÐ
ISG fusion assay. *, [35S]sul-
fate-labeled proteins. See
Materials and Methods for
details. (c) Immunoprecipita-
tion with ab100, ab175, and
ab69 using lysates obtained
from [35S]sulfate-labeled
PC12/PC2 cells (lanes 1Ð3) or
PC12 cells (lane 4). Arrows,
position of SgII (p86), and
the processing products p38,
p24, and p18.Urb et al. Fusion of ISGs in a Cell-free Assay 1835
firmed that there was no detectable p18 (Fig. 1 c, lane 4) as
expected since there is no PC2 in PC12 cells.
Optimization of the Processing Reaction
As detection of fusion between ISGs depends on the cata-
lytic activity of the PC2 enzyme it is important that the
conditions within the fused ISGs support optimal PC2 ac-
tivity to ensure that the processing reaction is not rate lim-
iting and will proceed to completion. In particular, the lu-
menal pH within the ISGs after fusion must be acidic to
achieve optimal enzymatic activity. The ISG preparations
from both the PC12 cells and the PC12/PC2 cells have a lu-
menal pH equivalent to that of the buffer used during
their isolation, i.e., pH 7.2. We have shown that when
these isolated ISGs are incubated at 48C in a low pH
buffer they will equilibrate to the pH of the buffer. Using
this equilibration step, performed at 48C for 30 min, we
can manipulate the lumenal pH of the ISG to promote ef-
ficient processing of SgII by PC2 in isolated ISGs (Urb et al.,
1997a).
We have previously demonstrated that p18 can be pro-
duced from [35S]sulfate-labeled SgII in ISGs isolated from
PC12/PC2 cells after equilibration at pH 5.5 followed by
incubation at 378C (Urb et al., 1997a). To obtain evidence
that the conditions required for fusion do not interfere
with the processing of SgII in vitro by PC2 we performed a
mock fusion assay with a PNS obtained from PC12/PC2
cells pulse labeled with [35S]sulfate for 10 min and chased
for 15 min. After this pulse labeling condition the [35S]sul-
fate-labeled SgII in this PNS is unprocessed (Urb et al.,
1997a). If this PNS, which contains [35S]sulfate-labeled
SgII and PC2 in the same ISG, is kept at 48C, equilibrated
to pH 5.5, and then incubated at 378C, SgII processing can
be detected by immunoprecipitation of p18 (Fig. 2 a, lane
1). Incubation at 378C before the equilibration to pH 5.5 in
the presence of ATP (Fig. 2 a, lane 2) under conditions
which mimic the fusion step in our assay does not interfere
with the generation of p18. In a parallel processing reac-
tion preceded by a mock fusion incubation using a PNS
from PC12 cells labeled and isolated by an identical proce-
dure, no p18 is detected (Fig. 2 a, lanes 3 and 4) as ex-
pected in the absence of PC2.
Reconstitution of ISGÐISG Fusion In Vitro
Fusion of ISGs, as detected by the appearance of p18, can
be observed when the donor PC2-ISGs are added to an ac-
ceptor PNS derived from [35S]sulfate-labeled PC12 cells
and the reaction mixture is incubated at 378C for fusion
and then processing (Fig. 2 b, lane 2). A low amount of
p18 can be detected if the fusion reaction is kept at 48C
(Fig. 2 b, lane 1). Addition of the PC2-ISGs after the fu-
sion reaction does not result in a significant signal over
background demonstrating that the processing reaction
does not support fusion (Fig. 2 b, lane 3). In the absence of
the donor PC2-ISGs a low amount of p18 is detected at
this exposure, and we define this as the PC2-independent
background. We attribute this background p18 signal
(seen in Fig. 2 b, lane 4) to a minor protease activity
present in PC12-ISGs. To maximize the p18 signal a 30-
min labeling protocol of the PC12 cells was thereafter
adopted and routinely used. All of the controls performed
Figure 2. Generation of p18 in a cell-free fusion assay. (a) Pro-
cessing of SgII in PC12/PC2 ISGs is not affected by previous in-
cubation for fusion. A PNS was prepared from PC12/PC2 cells
(lanes 1 and 2) or PC12 cells (lanes 3 and 4) labeled with a 10-min
pulse followed by a 15-min chase. Each PNS was then incubated
either at 48 or 378C under conditions which allow fusion in the
presence of ATP, then for processing at 378C for 45 min. (b) Re-
constitution of ISG fusion. A PNS was prepared from PC12 cells
labeled as above and incubated in the presence of 7 ml of PC2-
ISGs and ATP at 48 (lane 1) or 378C (lane 2) for 45 min. Alterna-
tively, the PC2-ISGs were added after the fusion incubation (lane
3) or omitted entirely (lane 4). After equilibration for 60 min on
ice, processing reactions were incubated at 378C for 45 min.
[35S]sulfate-labeled p18 was immunoprecipitated and subjected to
SDS-PAGE and autoradiography. Note the autoradiograph
shown in b was exposed for 2 mo. *, a high molecular weight band
which is brought down during the immunoprecipitation step by
binding nonspecifically to both protein AÐ and GÐSepharose.The Journal of Cell Biology, Volume 143, 1998 1836
in Fig. 2 were done with the extended labeling period and
gave the same result (data not shown). The high molecular
weight material present in all conditions in Fig. 2 is an uni-
dentified [35S]sulfate-labeled molecule which binds non-
specifically to the protein AÐ and protein GÐSepharose in-
dependently of added antibody.
The fusion reaction is both ATP and temperature de-
pendent (Fig. 3 a). Incubation at 48C or addition of hexo-
kinase in the presence of glucose resulted in no increase in
the production of p18 over the background level. Nonhy-
drolyzable analogues of ATP were unable to substitute for
ATP (Fig. 3 a) suggesting that ATP hydrolysis is necessary
for fusion to occur. The PC2-dependent p18 signal rou-
tinely obtained in the presence of ATP after a 378C incu-
bation in the assay was two- to five-fold greater than the
PC2-independent signal.
Characterization of ISGÐISG Fusion
ISGÐISG fusion required the presence of proteins on the
cytoplasmic surface of the donor ISGs. If the donor PC2-
ISGs were pretreated with trypsin before addition to the
assay there was a significant decrease in p18 production
(Fig. 3 b, lanes 3 and 4) compared with untreated (Fig. 3 b,
lane 2) and control samples (Fig. 3 b, lanes 5 and 6). To en-
sure that the p18 produced in the assay is not a conse-
quence of lysis we added trypsin to the reaction mixture
after the processing incubation. The trypsin was then
quenched by the addition of soybean trypsin inhibitor, ly-
sis buffer was added, and then the p18 was immunoprecip-
itated (Fig. 3 b, lane 7). Even after the low pH incubation,
p18 was protected from the action of trypsin and was thus
generated from SgII by PC2 within the fused ISGs and not
by external proteases. As expected, no p18 was detected if
trypsin was added in combination with Triton X-100 to al-
low the trypsin to gain access to the [35S]sulfate-labeled
p18 (Fig. 3 b, lane 8).
Optimization of the Assay
We estimate, based on the cell number in the original start-
ing material, that the amount of ISGs contained in 100 ml of
acceptor PNS is equivalent to 3 ml of donor ISGs. There-
fore, addition of 10 ml of donor ISGs containing PC2
(PC2-ISGs) to 100 ml of acceptor PNS would give approxi-
mately a 3:1 ratio between donor ISGs containing the en-
zyme and acceptor ISGs containing the substrate. To opti-
mize the PC2-dependent fusion signal, donor ISGs were
titrated into the assay at ratios from 1:1 to 10:1. Addition
of increasing amounts of donor PC2-ISGs, from 2.5Ð30 ml,
to the acceptor PNS stimulated the production of p18. Pro-
duction of p18 reached a plateau after addition of 20Ð30 ml
of PC2-ISGs (Fig. 4 a). A second round of immunoprecipi-
tation with anti-p18 antibodies demonstrated the first im-
munoprecipitation was quantitative and sufficient even
when using 30 ml of PC2-ISGs with 100 ml of acceptor PNS
(data not shown).
To optimize the efficiency of the assay, and to ensure
that neither incubation was limiting, the length of both the
fusion incubation and the processing incubation was var-
ied. Fusion between ISGs, assayed with a 45-min process-
ing reaction, occurred with a relatively linear increase over
time until z30 min when the production of p18 reached a
plateau (Fig. 4 b). Processing of SgII by PC2, assayed after
a 45-min fusion incubation, also increased with time (Fig. 4
c) and was significantly greater than the PC2-independent
signal at all time points. The PC2-independent signal re-
mained constant over time during the fusion reaction
whereas it increased with time during the processing incu-
bation until 90 min, suggesting that the background activ-
ity is dependent upon acidic pH. For the remainder of the
experiments described, fusion was performed for 30 min
and the processing reaction for 90 min ensuring that nei-
ther fusion nor processing were limiting.
Figure 3. Requirements for ISG fusion. (a) Nucleotides (1 mM
ATP and ATP-regenerating system, or 100 mM AMP-PNP) or
ATP-depletion mixture (25 U hexokinase in 3 mM glucose) were
added to the fusion reaction containing 100 ml of PNS from PC12
cells labeled for 30 min with [35S]sulfate with or without PC2-
ISGs. The reactions were incubated at 378 or 48C for 30 min and
then incubated for processing for 90 min. (b) Fusion requires
trypsin sensitive proteins and p18 is generated in the lumen of
membrane enclosed organelles. PC2-ISGs were pretreated with
trypsin (0.01 and 0.1 mg/ml trypsin [final concentration] which
corresponds to 20 and 200 ng trypsin/mg ISG protein) for 15 min
at 378C in the absence (lanes 3 and 4) or presence of STI (lanes 5
and 6). STI was added to the reactions shown in lanes 3 and 4,
and fusion was assayed in a standard reaction by incubation for
30 min at 378C, followed by processing for 45 min at 378C. Alter-
natively, the reaction mixture was treated with the highest con-
centration of trypsin (0.1 mg/ml) for 15 min at 378C after the pro-
cessing reaction in the absence (lane 7) or presence (lane 8) of
0.3% Triton X-100. p18 was immunoprecipitated and then sub-
jected to SDS-PAGE and autoradiography. Quantitation in a was
performed by densitometry. The data shown are from a represen-
tative experiment done in duplicates.Urb et al. Fusion of ISGs in a Cell-free Assay 1837
Characterization of Fusion Product
Incubation of ISGs containing [35S]sulfate-labeled SgII
with PC2-ISGs results in the appearance of [35S]sulfate-
labeled p18. To ensure that the vesicles which contained
the p18 were derived from the fusion of two populations of
ISGs, we studied the sedimentation behavior of the fused
ISGs by subcellular fractionation on sequential velocity
and equilibrium sucrose gradients. A fusion incubation
was performed as above and chilled to 48C while an equal
portion of the [35S]sulfate-labeled PC12-PNS was kept on
ice (starting material). Both the fusion reaction and the
starting material were subjected to velocity controlled cen-
trifugation. ISG containing fractions (fractions 2Ð4) were
pooled and either loaded on equilibrium gradients or a
portion (one-fifth) of each pool was incubated for process-
ing. The latter was analyzed after processing for the con-
tent of [35S]sulfate-labeled SgII or p18 (Fig. 5, a and b). In
the pool obtained after fusion (postfusion) [35S]sulfate-
labeled p18 (Fig. 5 b) can be detected but not in the pool
kept at 48C (prefusion). As expected, a decrease in the to-
tal [35S]sulfate-labeled SgII is detectable after fusion (Fig.
5 a), reflecting the processing of SgII to fragments in-
cluding p18 (Fig. 1). To verify that the vesicles containing
p18 were ISGs, the remaining four-fifths of the velocity
gradient pools were subjected to equilibrium gradient cen-
trifugation. After equilibrium gradient centrifugation and
fractionation, the fractions were analyzed for [35S]sulfate-
labeled SgII (Fig. 5 c) or [35S]sulfate-labeled p18 (Fig. 5 d).
The p18 containing vesicles produced by fusion (Fig. 5 d)
sedimented to the same position on the equilibrium gradi-
ent as the ISGs containing [35S]sulfate-labeled SgII in the
starting material (Fig. 5 c). This confirms that the fusion of
two ISGs results in a ÒhybridÓ ISG with similar properties
as the starting ISG. Interestingly, the hybrid ISG (Fig. 5 d)
displayed a slight increase in density, suggesting they were
larger than the original population of ISGs. This experi-
ment was also used to calculate the percentage of SgII pro-
cessed after fusion by comparing the amount of p86 in the
starting material with p86 after fusion and processing (Fig.
5 a, Table I, and see below).
Comparison of SgII Processing in Fused ISGs
with PC2-ISGs
Direct comparison of the extent of processing in the hy-
brid ISGs with the PC2-ISGs where the enzyme and sub-
strate are copackaged when ISGs are formed in the cell
also allowed us to estimate the fusion efficiency under the
standard conditions of the assay (Table I). A PNS from
PC12/PC2 cells labeled with [35S]sulfate was isolated and
incubated in a fusion assay under standard conditions ex-
cept that no unlabeled PC2-ISGs were added. The extent
of processing obtained was then compared with that ob-
served for the hybrid ISGs formed in a typical fusion as-
say. The relative processing index in hybrid ISGs was
found to be z25% compared with 69% for PC2-ISGs.
Figure 4. Optimization of the fusion assay conditions. (a) Increasing amounts of PC2-ISGs
(from 0 to 30 ml) were added to 100 ml of PNS from PC12 cells labeled for 30 min with
[35S]sulfate and then assayed for fusion by incubation for 30 min at 378C followed by the
processing reaction for 90 min at 378C. Top and bottom panel are from separate represen-
tative experiments. (b) Time course of fusion. 20 ml of PC2-ISGs were added to the assay
mixture and incubated for fusion. At the time points shown the samples were transferred
to ice and diluted with pH 5.5 buffer and subjected to the processing at 378C for 45 min. (c)
Time course of processing. Fusion assays were performed with either 0 or 20 ml of PC2-
ISGs for 45 min at 378C. The reactions were then subjected to processing reactions at 378C
for times ranging from 0 to 150 min. p18 was immunoprecipitated and quantified as de-
scribed in Fig. 3 and the PC2-independent background was subtracted. Data shown are
from representative experiments done in duplicate.The Journal of Cell Biology, Volume 143, 1998 1838
Thus, the efficiency of fusion between ISGs in the assay
was estimated to be z37%.
Comparison of the time course of SgII processing in the
hybrid ISG (Fig. 4 c) and in ISGs isolated from PC12/PC2
cells in a previous study (Urb et al., 1997a) reveals that
SgII processing in hybrid ISGs occurs with different kinet-
ics. In the PC2-ISGs 50% of the maximum processing sig-
nal is reached after 15 min of incubation (Fig. 5 in Urb et
al., 1997a) whereas the processing signal in the hybrid
ISGs is less than 10% of the maximum signal at that time.
In addition, the maximum p18 signal in the PC2-ISGs is
reached at 60 min compared with 90 min for the hybrid
ISGs. These differences may be due to the fact that in the
hybrid ISGs the PC2 enzyme will process the PC12-ISG
derived [35S]sulfate-labeled SgII as well as the unlabeled
SgII contained in the PC2-ISGs. If one assumes that one
PC2-ISG fuses with one PC12-ISG containing [35S]sulfate-
labeled SgII to generate a hybrid ISG, at most only half of
the total SgII processed at any one time will be [35S]sul-
fate-labeled, thus processing of [35S]sulfate-labeled SgII
will take about twice as long in the hybrid ISG.
Fusion Only Occurs between ISGs and ISGs
The ISG is defined as an early stage intermediate that can
undergo changes such as acidification, membrane remod-
eling, and homotypic fusion (Tooze, 1991) whereas the
MSG is a late stage stable organelle which has a constant
size and content. One prediction of these definitions is that
fusion should be specific to the early stage and will not oc-
cur at the later mature granule stage. Two approaches
were used to investigate the stage specificity of fusion: first
we asked whether MSGs were able to substitute for ISGs
in the fusion assay and second whether ISGs or MSGs
could compete for generation of labeled p18.
MSGs, isolated from PC12/PC2 cells, were substituted
for the PC2-ISGs in a standard assay (Fig. 6 a). MSGs
from PC12/PC2 cells contain large amounts of the mature
PC2 enzyme (Ditti and Tooze, 1995; data not shown) and
thus the processing of the [35S]sulfate-labeled SgII should
be readily detected if fusion occurs. Substitution of the
PC2-ISGs with either one or two times the amount of
PC2-MSGs did not result in the appearance of appreciable
amounts of p18 over the PC2-independent background.
The specificity of fusion was next tested by competition
for fusion using ISGs isolated from PC12 cells (PC12-
IGSs) that contain cold substrate but no enzyme. Addition
of increasing amounts of cold PC12-IGSs to the complete
reaction mixture (containing 100 ml of [35S]sulfate-labeled
PNS from PC12 cells, 10 ml PC2-ISGs, ATP, and an ATP-
regenerating system) resulted in a decrease in the amount
of p18 produced (Fig. 6 b, open squares). When the ratio of
PC12-ISGs to PC2-ISGs added to the assay was z3:1, a
50% reduction in the p18 signal was detected. Impor-
tantly, the addition of an equivalent amount of MSGs, pre-
pared from PC12 cells (PC12-MSGs), to the assay (i.e., 3
MSGs:1 ISG) resulted in no competition (Fig. 6 b, closed
diamond) confirming the observation that MSGs do not
fuse with ISGs.
Competition leading to a decrease of the total p18 signal
could result from either competition for fusion or enzyme.
If the ISGs have a limited capacity to fuse they will be-
Figure 5. Characterization of the membranes containing p18 af-
ter fusion. A PNS was prepared from PC12 cells labeled with
[35S]sulfate for 30 min. One-half of this PNS was kept on ice while
the remainder was incubated under standard conditions for fu-
sion with PC2-ISGs. Both the starting material and the reaction
mixture were loaded onto velocity gradients and subjected to
fractionation. Fractions 2Ð4 from the velocity gradients were
pooled, and one-fifths were analyzed for p18 using the standard
incubation for processing while the remaining four-fifths were
subjected to equilibrium gradient centrifugation and fraction-
ation. (a) Samples of the velocity gradient pools analyzed for p86,
or (b) subjected to processing and then immunoprecipitation with
anti-p18 antibodies from either the starting material (pre fusion)
or after fusion (post fusion). (c) Samples of equilibrium gradient
fractions 5Ð11 from the gradient loaded with the starting material
were analyzed for p86, or (d) equilibrium gradient fractions 5Ð11
from the gradient loaded with the fusion reaction were subjected
to processing followed by immunoprecipitation to detect p18 as
above. Analysis of p86 was performed by SDS-PAGE followed
by fluorography.
Table I. Determination of the Fusion Efficiency
PNS PNS VG
PC2-ISGs
fusion NR*
1 processing
ip 175
hybrid ISGs
1 fusion
1 processing
ip 175
hybrid ISGs
1 fusion
1 processing
total p86
p86 in starting material (st) 76.0 62.73 34.2
p86 after incubations (fin) 23.6 46.76 20.8
Percent processing efficiency 69.0% 25.5% 39.2%
(p86st 2 p86fin) 3 100
(p86st)
Percent fusion efficiency 100% 37% Ñ
*NR, not required.
A PNS was prepared from PC12 or PC12/PC2 cells labelled for 30 min with [35S]sul-
phate. Fusion assays were performed as described using a PNS or enriched fractions
(VG). The amount of p86 before (starting material 5 st) and after the fusion reaction
(final 5 fin) was determined by immunoprecipitation with Ab 175 (ip 175) or by direct
analysis of the total p86 from enriched fractions containing ISGs (Fig. 5) and is ex-
pressed as arbitrary units. Processing efficiency is calculated from the values shown
which are from representative experiments. Fusion efficiency in hybrid ISGs was ex-
pressed as a percentage of SGII processing in intact PC2-ISGs using the values ob-
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come refractory to fusion after a defined number of fusion
events. Thus, addition of excess ISGs will result in compe-
tition and a decrease in the p18 produced. However, it is
equally possible that competition is the result of unlabeled
substrate competing with labeled substrate for enzyme in
an unrestricted fusion reaction where PC2 is limiting. Fur-
ther experiments need to be carried out to confirm the
mode of competition, however, whether it is a result of
competition for fusion or competition for substrate, both
depend on an initial fusion event between ISGs.
Cytosol Dependence of ISGÐISG Fusion
To determine if ISGÐISG fusion required cytosolic com-
ponents we modified the assay by isolating the membranes
and membrane bound organelles from the acceptor PNS
derived from the [35S]sulfate-labeled PC12 cells. The iso-
lated membranes were resuspended in buffer or cytosol
prepared from PC12 cells, and tested for activity in the fu-
sion assay. Comparison of the results obtained with the
PNS assay showed that the efficiency of the fusion reac-
tion with the membrane pellet was similar and required
cytosol (Fig. 7 a). To obtain a more abundant source of cy-
tosol we explored the feasibility of substituting cytosol
from tissues, such as rat liver, for the PC12 cell cytosol.
Rat liver cytosol was demonstrated to be active in the fu-
sion assay and the maximum fusion signal was obtained
with z7 mg/ml cytosol which was comparable to PC12 cell
cytosol.
We next investigated the requirements for the nucle-
otides ATP and GTP in the cytosol-dependent assay. Rat
liver cytosol was prepared and added to the assay with ei-
ther ATP, GTP, or GTPgS. Both ATP and GTP together
were required for maximum efficiency, and interestingly
GTPgS could substitute for GTP but not ATP (Fig. 7 b).
Although the requirement for ATP may be attributed to a
requirement for NSF (see below) we do not yet under-
stand the GTP requirement. It may be that a GTP-binding
protein is required in its GTP bound form for fusion to
occur.
Fusion of ISGs Can Occur with an Enriched 
Preparation of Acceptor ISGs
To ensure that the fusion we measure was homotypic, that
is occurring between identical populations of ISGs, we at-
tempted to reconstitute fusion using an acceptor ISG frac-
tion of comparable purity to the donor PC2-ISGs in the
presence of cytosol. Several attempts to do so failed (data
not shown) and we speculate that centrifugation through
two consecutive sucrose gradients removes essential com-
ponents that are required on at least one ISG population.
To overcome this problem we used a partially purified
pool enriched in post-Golgi vesicles, in particular ISGs,
which does not contain detectable levels of TGN mem-
branes. Isolation of acceptor ISGs from PC12 cells labeled
with [35S]sulfate for 30 min was performed using the su-
crose velocity gradients normally used to prepare donor
PC2-ISGs. The pool of fractions 2Ð4 which was then used
in a standard assay supplemented with rat liver cytosol
with or without PC2 ISGs. Rat liver cytosol was added be-
cause the velocity gradient fractions are largely depleted
of cytosolic proteins which remain in the load. Fusion was
detected in the reaction mixtures containing the velocity
gradient fractions and PC2-ISGs and cytosol (Fig. 8). Al-
though the total signal was reduced compared with that
obtained with a membrane pellet derived from a PNS of
[35S]sulfate-labeled PC12 cells, when normalized to back-
ground the PC2-dependent fusion signal obtained with the
enriched donor pool (1.9-fold over background) was com-
parable to that obtained with a membrane pellet (1.7-fold
over background, Fig. 8).
Role of NEM-sensitive Proteins in ISG Fusion
Previously identified proteins involved in membrane fu-
sion reactions include the ATPases NSF and p97 both of
which can be inactivated by NEM treatment. Analysis of
the distribution of these NEM-sensitive proteins in the
membrane fractions and rat liver cytosol used in the assay
is shown in Fig. 9 a. The majority of the NSF contained in
the PNS (z3 mg NSF per mg of total protein) remains as-
sociated with the membranes after preparation of the
membrane pellet (MP). Most of the a-SNAP present in
the PNS was recovered on the membrane pellet, but very
little was detected on PC2-ISGs. The distribution of p97
on the PNS and membrane pellet is similar compared with
NSF. However, there was very little p47 detected on the
membrane pellet or the PC2-ISG fraction.
To explore the possibility that one, or both of these
complexes, are required for fusion we treated either the
PC12 cell membrane pellet, containing [35S]sulfate-labeled
SgII, rat liver cytosol, or both with NEM (Fig. 9 b, left).
Treatment of both membranes and cytosol inhibited fu-
sion more than 90%. In the presence of NEM treated rat
liver cytosol the efficiency of fusion of untreated mem-
branes was only z30% of the control value. The fusion ef-
ficiency of NEM-treated membranes could be recovered
Figure 6. MSGs cannot fuse with ISGs. (a) PC2-ISGs, or one or
two times the volume of MSGs prepared from PC12/PC2 cells
were added to the fusion reactions containing 100 ml of PNS from
PC12 cells labeled with 30 min [35S]sulfate. (b) Increasing
amounts of ISGs (open squares) or 30 ml of MSGs (solid dia-
mond) prepared from PC12 cells, were added to fusion reactions
containing 10 ml of PC2-ISGs and 100 ml of PNS from labeled
PC12 cells. Fusion reactions, carried out for 30 min at 378C were
followed by processing reactions for 90 min at 378C. p18 was im-
munoprecipitated from the reactions and quantitated as above.
Results shown are after subtraction of the PC2-independent
background and are representative experiments done in dupli-
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to z40% of the original fusion efficiency by the addition
of untreated rat liver cytosol to the NEM treated mem-
branes.
To determine if we could attribute the decrease in fu-
sion efficiency after NEM treatment to inactivation of
NSF or p97 we added recombinant NSF and a-SNAP, or
purified p97 and recombinant p47 to the fusion assay af-
ter various NEM treatments. Using NEM-treated mem-
branes, addition of NSF to NEM treated rat liver cytosol
could restore fusion nearly to the level observed after ad-
dition of untreated rat liver cytosol (Fig. 9 c). Addition of
a-SNAP did not increase the rescue by NSF, in fact was
slightly inhibitory (data not shown). Interestingly, supple-
menting untreated cytosol with similar amounts of NSF
stimulated the recovery of NEM-treated membranes to al-
most 90% of the control value (Fig. 9 b, right). Addition of
a complex of purified p97 and his-tagged p47 to NEM-
treated membranes and NEM-treated cytosol did not re-
store fusion (Fig. 9 c). Neither did the addition of p97/47
to untreated cytosol restore the ability of NEM-treated
membranes to undergo fusion (Fig. 8 b,  right). Experi-
ments were also performed using purified p97 alone, or a
crude p97Ðp47 fraction (purified by 40% ammonium sul-
fate precipitation of rat liver cytosol, then sucrose gradient
centrifugation using the method of Kondo et al. [1997]),
both of which were unable to rescue NEM-treated mem-
branes and cytosol.
Discussion
Fusion of ISGs has been reconstituted in a cell-free assay
based on the proteolytic processing of a substrate prohor-
mone (SgII) by a prohormone convertase (PC2). An im-
portant feature of the assay is the fact that proteolytic pro-
cessing of substrates by PC2 only occurs in the regulated
secretory pathway after the substrates and enzymes are
packaged into secretory granules (Urb et al., 1997a). Us-
ing this assay we have determined that ISG fusion is de-
pendent upon cytosolic and membrane associated pro-
teins, ATP, GTP, and physiological temperature. Fusion is
specific for ISGs in that MSGs cannot fuse with ISGs, and
competition is observed after addition of excess ISGs, but
not MSGs, derived from unlabeled PC12 cells.
In the absence of PC2-ISGs we can detect a low amount
of endopeptidase activity which processes the labeled SgII
in the PC12-ISGs. This background signal is produced dur-
ing the processing reaction by an endogenous protease
present in PC12 cell ISGs. This endopeptidase activity is
not detected in intact PC12 cells after prolonged [35S]sul-
fate-labeling during which time the MSGs accumulate un-
processed [35S]sulfate-labeled SgII. Furthermore, subcel-
lular fractionation data suggest that the activity is found in
ISGs but not MSGs (data not shown). We speculate that
this unknown endopeptidase activity may have a pH opti-
mum closer to pH 5.5 than 6.3, and therefore is normally
inactive in ISGs. Furthermore, this enzyme might be re-
moved from ISGs during maturation and thus never reach
the more acidic milieu of the MSG where it would be ac-
tive. Additional information about the nature and function
of this enzyme requires further study.
The assay described reconstitutes ISGÐISG fusion, and
was developed with the aim of understanding the role of
fusion in MSG biogenesis. Homotypic fusion, defined as the
fusion of two like compartments, is thought to be involved
in the steady-state maintenance of organelles, unlike het-
erotypic fusion which results in the transfer of molecules
Figure 7. Cytosol-dependent reconstitution of ISG fusion. (a) A membrane pellet (MP) was prepared from 100 ml of PNS obtained
from PC12 cells labeled for 30 min with [35S]sulfate. An equal volume of PNS was used as control. PC2-ISGs (10 ml), and PC12 cell cyto-
sol (final concentration 7 mg/ml) was added to the reaction mixtures as indicated. Fusion and processing was carried out under standard
conditions. p18 was immunoprecipitated and quantitated as described above. (b) A standard fusion reaction was performed using a MP
prepared from the PNS of PC12 cells labeled as above, in the presence or absence of 10 ml of PC2-ISGs, rat brain cytosol (final amounts
7 mg/ml), and nucleotides as indicated. p18 was immunoprecipitated and quantitated as described above. Data shown are representative
experiments performed in duplicate.Urb et al. Fusion of ISGs in a Cell-free Assay 1841
and lipids from one compartment to another. Examples of
homotypic fusion include the reassembly of the ER (Lat-
terich et al., 1995; Turner et al., 1997), the Golgi complex
(Acharya et al., 1995b; Rabouille et al., 1995b), endosome-
endosome fusion (Gruenberg and Howell, 1986; Diaz et
al., 1988; Woodman and Warren, 1988), lysosomeÐlyso-
some fusion (Ward et al., 1997) and vacuoleÐvacuole fu-
sion (Conradt et al., 1992).
In the case of assays which rely on internalized markers
to define the endocytotic compartments (for example see
Gruenberg and Howell, 1986; Diaz et al., 1988), fusion is
assumed to be homotypic if the compartments undergoing
fusion contain markers internalized for the same length of
time. In the ISGÐISG fusion assay described here fusion
can potentially occur amongst heterologous populations of
ISGs defined by the [35S]sulfate-labeling protocol. ISGs
form de novo from the TGN then mature into MSGs. Mat-
uration of ISGs takes place over a relatively long period of
time (t1/2 5 z45 min), compared with the time it takes an
ISG to bud (budding t1/2 5 z5 min; Tooze and Huttner,
1990). The possibility therefore exists that the labeled
ISGs in the assay are at different stages of maturation, and
consequently might display variable fusionogenicity. Al-
Figure 8. Fusion occurs with enriched acceptor ISGs. A mem-
brane pellet (MP) or velocity gradient (VG) fraction (pool of
fractions 2Ð4) were isolated from a PNS obtained from PC12 cells
labeled with [35S]sulfate for 30 min. A standard reaction was per-
formed with or without 10 ml of PC2-ISGs and with or without rat
liver cytosol. After a 30-min incubation for fusion, processing was
performed for 90 min at 378C. p18 was immunoprecipitated and
quantitated as above. Data shown is of representative experiment
performed in triplicate (error bars are 6SD of the mean) ex-
pressed as percent of the control. For comparison, the PC2-
dependent signal is shown relative to the PC2-independent signal
as an inset to emphasize that ISGÐISG fusion is comparable in
the MP and VG fractions.
Figure 9. NSF can rescue the inhibition of ISG fusion after NEM
treatment. (a) Immunoblot of a PNS, membrane pellet (MP) ob-
tained from the PNS, PC2-ISGs, and rat liver cytosol with anti-
bodies directed against p97, p47, NSF, and a-SNAP. The blot was
prepared from material loaded in amounts which are propor-
tional to that in the assay, i.e., 110 mg of a PNS, 38.5 mg of MP, 4.1 mg
of ISGs, 49 mg of rat liver cytosol. Bound antibodies were de-
tected using 125I-protein A. (b) NEM treatment was performed
on the membrane pellet obtained from a PNS of PC12 cells la-
beled with [35S]sulfate for 30 min or rat liver cytosol or both. A
fusion assay was performed with the treated or untreated compo-
nents using 10 ml of PC2-ISGs. NSF (19 mg/ml; 230 nM) or p97/
p47 (28 mg/ml p97; 290 nM p97) was added to NEM-treated
membranes and cytosol before incubation for fusion. (c) NSF can
rescue NEM inhibition of fusion. NEM-treated membrane pellet
was incubated with either rat liver cytosol or NEM-treated rat
liver cytosol in the presence or absence of NSF, p94/p47 in a stan-
dard fusion assay with 10 ml of PC2-ISGs. Values shown are after
subtraction of the PC2-independent background and are repre-
sentative of three independent experiments for NSF and two in-
dependent experiments for p97/47 performed in duplicates or
triplicates (error bars are 6SD of the mean).The Journal of Cell Biology, Volume 143, 1998 1842
though there might be subpopulations of ISGs between
which we can not discriminate, we define this fusion as ho-
motypic in contrast with heterotypic fusion of ISGs with
the plasma membrane.
Key components required for either or both heterotypic
and homotypic membrane fusion are the related ATPases,
NSF and p97 (for review see Mellman, 1995; Whiteheart
and Kubalek, 1995; Woodman, 1997). To begin to under-
stand the exact nature of ISGÐISG fusion we asked if ei-
ther or both of these molecules were required. We found
that NSF, but not p97, is required for fusion of ISGs. NEM
treatment of cytosol and membranes resulted in inhibition
of fusion, which could be rescued by the addition of NSF.
We found that a-SNAP was not required for NSF activity,
and the addition of a-SNAP alone had no effect. In light
of the results from the reconstitution of homotypic fusion
between Golgi membranes (Acharya et al., 1995a; Rabou-
ille et al., 1995a) one might have anticipated a role for p97
in ISG fusion. We found that addition of p97, or a complex
of p97 and p47, to NEM-treated membranes and cytosol
was not sufficient to rescue fusion.
The distinction between the function of NSF and p97 in
heterotypic fusion versus homotypic fusion is somewhat
blurred by the ability of NSF to rescue NEM-treated Golgi
membranes (Acharya et al., 1995a; Rabouille et al., 1995a)
in the presence of a-SNAP, g-SNAP, and p115, and the de-
monstration that both p47 and a-SNAP bind the t-SNARE
syntaxin 5 (Rabouille, 1998). In addition, homotypic fu-
sion between yeast vacuoles, mammalian endosomes, and
lysosomes has been shown to require NSF (Diaz et al.,
1989; Rodriguez, et al., 1994; Robinson, et al., 1997) and
fusion between yeast vacuoles and mammalian endosomes
has been shown not to require cdc48p (Mayer et al., 1996)
or p97 (Robinson et al., 1997), respectively. Thus, until we
obtain more data on the exact role of either NSF or p97 in
membrane fusion, a requirement for one or the other does
not seem to be a primary factor in classifying fusion events
as either homotypic or heterotypic.
What is the purpose of ISGÐISG fusion? We propose
that fusion of ISGs with each other is an integral part of
the maturation process and may be a prerequisite for post-
TGN sorting of proteins from the maturing ISG. Fusion of
ISGs may be necessary to create enough excess membrane
to form a clathrin-coated vesicle (CCV) from the ISG.
Formation of one CCVs from an ISG (80-nm-diam) would
result in the removal of nearly one-half the surface area of
the ISG. If three to five ISGs fuse to form a MSG (120-
nm-diam) (Tooze et al., 1991) enough excess membrane
would become available to allow two to seven CCVs to
form. In addition, fusion of ISGs might be a prerequisite
for formation of CCVs by increasing for example the num-
ber of AP-1Ðbinding sites present in the ISG. Furin, a
TGN-resident endopeptidase and both mannose-6-phos-
phate receptors (MPRs) associate with AP-1 and are re-
moved in CCVs which bud from the ISGs (Ditti et al.,
1996, 1997; Klumperman, 1998; Kuliawat, et al., 1997).
Other molecules which are not found in MSGs such as cer-
tain isoforms of peptidylglycine-a-amidating-mono-oxygen-
ase (Milgram et al., 1994), as well as soluble molecules
such as C-peptide (Kuliawat and Arvan, 1994) may also be
present in these CCVs although how they are selected is
not clear.
If ISG fusion is part of the maturation process it follows
that after maturation is completed, homotypic fusion
would no longer be required. In agreement with this we
have shown here that MSGs can no longer fuse with ISGs.
It is possible that the ISGÐISG fusion machinery maybe
gradually inactivated during maturation. We have previ-
ously shown that ISGs have a less acidic luminal pH than
MSGs (pH 6.3 versus pH 5.5) and proposed that the de-
crease in pH during maturation may be a direct conse-
quence of the membrane remodelling events during matu-
ration (Urb et al., 1997a). Increasing lumenal acidity may
influence the properties of both the membrane and pro-
teins within the membrane and might thus modify the fu-
sion competence of the secretory granule. An alternative
but not exclusive explanation maybe that factors involved
in homotypic fusion of ISGs, for instance a t-SNARE, are
removed during maturation by budding of CCVs or consti-
tutive-like secretory vesicles such that the MSG is left with
only the molecule(s), for instance a v-SNARE, required to
mediate heterotypic fusion with the plasma membrane
during regulated exocytosis. Control of the final size of the
MSG would then be dictated by the number of ISG fusion
events needed to generate enough vesicles to remove all
the SNAREs involved in ISG fusion.
There are to date two possible candidate t-SNAREs
that may be involved in ISG fusion, syntaxin 3 and 6. Syn-
taxin 3 has been localized to zymogen granules (Gaisano
et al., 1996) whereas syntaxin 6 has been localized to ISGs
in PC12 cells (Klumperman, 1998). Syntaxin 6 has been
shown to be present in coated buds emanating from the
ISGs as well as in CCVs, endosomes, (Klumperman, 1998),
and in TGN membranes (Bock, et al., 1997; Klumperman,
1998). It has been proposed that syntaxin 6 is involved
in targeting the CCVs to an endosomal compartment
(Klumperman, 1998). It is equally plausible that syntaxin 6
is involved in ISG fusion and only subsequently removed
by CCVs together with furin and MPR and targeted to the
endosome and/or returned to the TGN.
Selection and removal of putative sorting receptors,
membrane proteins, or missorted cargo before regulated
exocytosis is the most important goal of maturation and is
critical for the homeostasis of the organism. Although
sorting and fusion events during secretory granule biogen-
esis are likely to be linked, more experiments are required
to understand when and why ISGs lose their ability to fuse
with each other and how this is controlled to generate a
MSG. The assay described here represents an ideal experi-
mental system to investigate secretory granule biogenesis. 
We thank all the past and present members of the Tooze and Warren labs
for helpful discussions. We are grateful to G. Warren, G. Schiavo, and J.
Tooze (all from ICRF, London, UK) for critically reading the manuscript
as well as for discussions, advice, and encouragement. We thank H.
Kondo for generously supplying purified p97, p97Ðp47 complex, and his-
tagged p47 as well as for his time and advice.
Received for publication 6 July 1998 and in revised form 9 October 1998.
References
Acharya, U., R. Jacobs, J.M. Peters, N. Watson, M.G. Farquhar, and V. Mal-
hotra. 1995a. The formation of Golgi stacks from vesiculated Golgi mem-
branes requires two distinct fusion events. Cell. 82:895Ð904.
Acharya, U., J.M. McCaffery, R. Jacobs, and V. Malhotra. 1995b. Reconstitu-
tion of vesiculated Golgi membranes into stacks of cisternae: requirement ofUrb et al. Fusion of ISGs in a Cell-free Assay 1843
NSF in stack formation. J. Cell Biol. 129:577Ð589.
Advani, R.J., H.-R. Bae, J.B. Bock, D.S. Chao, Y.-C. Doung, R. Prekeris, J.-S.
Yoo, and R.H. Scheller. 1998. Seven novel mammalian SNARE proteins lo-
calize to distinct membrane compartments. J. Biol. Chem. 273:10317Ð10324.
Barr, F.A., A. Leyte, S. Mollner, T. Pfeuffer, S.A. Tooze, and W.B. Huttner.
1991. Trimeric G-proteins of the trans-Golgi network are involved in the for-
mation of constitutive secretory vesicles and immature secretory granules.
FEBS (Fed. Eur. Biochem. Soc.) Lett. 294:239Ð243.
Bennett, D.L., E.M. Bailyes, E. Nielsen, P.C. Guest, N.G. Rutherford, S.D.
Arden, and J.C. Hutton. 1992. Identification of the type 2 proinsulin process-
ing endopeptidase as PC2, a member of the eukaryote subtilisin family. J.
Biol. Chem. 267:15229Ð15236.
Block, M.R., B.S. Glick, C.A. Wilcox, F.T. Wieland, and J.E. Rothman. 1988.
Purification of an N-ethylmaleimide-sensitive protein catalyzing vesicular
transport.  Proc. Natl. Acad. Sci. USA. 85:7852Ð7856.
Bock, J.B., and R.H. Scheller. 1997. Protein transport A fusion of new ideas.
Nature. 36:133Ð135.
Bock, J.B., J. Klumperman, S. Davanger, and R.H. Scheller. 1997. Syntaxin 6
functions in trans Golgi network vesicle trafficking. Mol. Biol. Cell. 8:1261Ð
1271.
Burgess, T.L., and R.B. Kelly. 1987. Constitutive and regulated secretion of
proteins. Annu. Rev. Cell Biol. 3:243Ð293.
Carnell, L., and H.P. Moore. 1994. Transport via the regulated secretory path-
way in semi-intact PC12 cells: role of intra-cisternal calcium and pH in the
transport and sorting of secretogranin II. J. Cell Biol. 127:693Ð705.
Chen, Y.G., A. Siddhanta, C.D. Austin, S.M. Hammond, T.C. Sung, M.A. Froh-
man, A.J. Morris, and D. Shields. 1997. Phospholipase D stimulates release
of nascent secretory vesicles from the trans-Golgi network. J. Cell Biol. 138:
495Ð504.
Clary, D., I.C. Griff, and J.E. Rothman. 1990. SNAPs, a family of NSF attach-
ment proteins involved in intracellular membrane fusion in animals and
yeast.  Cell. 61:723Ð733.
Conradt, B., J. Shaw, T. Vida, S. Emr, and W. Wickner. 1992. In vitro reactions
of vacuole inheritance in Saccharomyces cerevisiae. J. Cell Biol. 119:1469Ð
1479.
Cool, D.R., E. Normant, F.-s. Shen, H.-C. Chen, L. Pannell, Y. Zhang, and Y.P.
Loh. 1997. Carboxypeptidase E is a regulated secretory pathway sorting re-
ceptor: genetic obliteration leads to endocrine disorders in Cpefat mice. Cell.
88:73Ð83.
Davey, J., S.M. Hurtley, and G. Warren. 1985. Reconstitution of an endocytic
fusion event in a cell-free system. Cell. 43:643Ð652.
Diaz, R., L. Mayorga, and P. Stahl. 1988. In vitro fusion of endosomes following
receptor-mediated endocytosis. J. Biol. Chem. 263:6093Ð6100.
Diaz, R., L. Mayorga, P.J. Weidman, J.E. Rothman, and P.D. Stahl. 1989. Vesi-
cle fusion following receptor-mediated endocytosis requires a protein active
in Golgi transport. Nature. 339:398Ð400.
Ditti, A., and S. Tooze. 1995. Characterization of the endopeptidase PC2 ac-
tivity towards SgII in stably transfected PC12 cells. Biochem. J. 310:777Ð787.
Ditti, A.S., N. Hajibagheri, and S.A. Tooze. 1996. The AP-1 adaptor complex
binds to immature secretory granules from PC12 cells, and is regulated by
ADP- ribosylation factor. J. Cell Biol. 132:523Ð536.
Ditti, A.S., L. Thomas, G. Thomas, and S.A. Tooze. 1997. Interaction of furin
in immature secretory granules from neuroendocrine cells with the AP-1
adaptor complex is modulated by casein kinase II phosphorylation. EMBO
(Eur. Mol. Biol. Organ.) J. 16:4859Ð4870.
Gaisano, H.Y., M. Ghai, P.N. Malkus, L. Sheu, A. Bouquillion, M.K. Bennett,
and W.S. Trimble. 1996. Distinct cellular locations of the syntaxin family of
proteins in rat pancreatic acinar cells. Mol. Biol. Cell. 7:2019Ð2027.
Gerdes, H.-H., E. Phillips, and W.B. Huttner. 1988. The primary structure of rat
secretogranin II deduces from a cDNA sequence. Nucl. Acids Res. 16:11811.
Gtte, M., and G.F. von Mollard. 1998. A new beat for the SNARE drum.
Trends Cell Biol. 8:215Ð218.
Gruenberg, J.E., and K.E. Howell. 1986. Reconstitution of vesicle fusions oc-
curring in endocytosis with a cell-free system. EMBO (Eur. Mol. Biol. Or-
gan.) J. 5:3091Ð3101.
Heumann, R., V. Kachel, and H. Thoenen. 1983. Relationship between NGF-
mediated volume increase and Òpriming effectÓ in fast and slow reacting
clones of PC12 pheochromocytoma cells. Exp. Cell Res. 145:179Ð190.
Irminger, J.-C., B. Verchere, K. Meyer, and P.A. Halban. 1997. Proinsulin tar-
geting to the regulated pathway is not impaired in carboxypeptidase E-defi-
cient Cpefat/Cpefat mice. J. Biol. Chem. 272:27532Ð27534.
Itin, C., C. Rancanos, Y. Nakajima, and S.R. Pfeffer. 1997. A novel assay re-
veals a role for soluble N-ethylmaleimide-sensitive fusion attachment pro-
tein in mannose 6-phosphate receptor transport from endosomes to the
trans-Golgi network. J. Biol. Chem. 272:27737Ð27744.
Klumperman, J., R. Kuliawat, J.M. Griffith, H.J. Geuze, and P. Arvan. 1998.
Mannose 6-phosphate receptors are sorted from immature secretory gran-
ules via adaptor protein AP-1, clathrin, and syntaxin 6-positive vesicles. J.
Cell Biol. 141:359Ð371.
Kondo, H., C. Rabouille, R. Newman, T.P. Levine, D. Pappin, P. Freemont,
and G. Warren. 1997. p47 is a cofactor for p97-mediated membrane fusion.
Nature. 388:75Ð78.
Kuliawat, R., and P. Arvan. 1994. Distinct molecular mechanisms for protein
sorting within immature secretory granules of pancreatic b-cells. J. Cell Biol.
126:77Ð86.
Kuliawat, R., J. Klumperman, T. Ludwig, and P. Arvan. 1997. Differential sort-
ing of lysosomal enzymes out of the regulated secretory pathway in pancre-
atic b-cells. J. Cell Biol. 137:595Ð608.
Laslop, A., C. Weiss, D. Savaria, C. Eiter, S.A. Tooze, N.G. Seidah, and H.
Winkler. 1998. Proteolytic processing of chromogranin B and secretogranin
II by prohormone convertases. J. Neurochem. 70:374Ð383.
Latterich, M., K.U. Frohlich, and R. Schekman. 1995. Membrane fusion and the
cell cycle: Cdc48p participates in the fusion of ER membranes. Cell. 82:885Ð
893.
Lee, R.W.H., and W.B. Huttner. 1983. Tyrosine-O-sulfated proteins of PC12
pheochromocytoma cells and their sulfation by a tyrosylprotein sulfotrans-
ferase. J. Biol. Chem. 258:11326Ð11334.
Mayer, A., W. Wickner, and A. Haas. 1996. Sec18p (NSF)-driven release of
Sec17p (a-SNAP) can precede docking and fusion of yeast vacuoles. Cell. 85:
83Ð94.
Mellman, I. 1995. Enigma variations: protein mediators of membrane fusion.
Cell. 82:869Ð872.
Milgram, S.L., B.A. Eipper, and D.E. Mains. 1994. Differential trafficking of
soluble and integral membrane secretory granule-associated proteins. J. Cell
Biol. 124:33Ð41.
Nichols, J.B., C. Ungermann, H.R.B. Pelham, W.T. Wickner, and A. Haas.
1997. Homotypic vacuolar fusion mediated by t-and v-SNAREs. Nature. 387:
199Ð202.
Niehrs, C., J. Stinchcombe, and W.B. Huttner. 1992. Two membrane-bound
forms of tyrosylprotein sulfotransferase as revealed by phase partitioning in
Triton X-114. Eur. J. Cell Biol. 58:35Ð43.
Ohashi, M., K. Jan de Vries, R. Frank, G. Snoek, V. Bankaitis, K. Wirtz, and
W.B. Huttner. 1995. A role for phosphatidylinositol transfer protein in
secretory vesicle formation. Nature. 377:544Ð547.
Orci, L., P. Halban, A. Perrelet, M. Amherdt, M. Ravazzola, and R.G.W.
Anderson. 1994. pH-independent and -dependent cleavage of proinsulin in
the same secretory vesicle. J. Cell Biol. 126:1149Ð1156.
Patel, S.K., F.E. Indig, N. Olivieri, N.D. Levine, and M. Latterich. 1998. Or-
ganelle membrane fusion: a novel function for the syntaxin homolog Ufe1p
in ER membrane fusion. Cell. 92:611Ð620.
Rabouille, C., T.P. Levine, J.M. Peters, and G. Warren. 1995a. An NSF-like
ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi frag-
ments. Cell. 82:905Ð914.
Rabouille, C., T. Misteli, R. Watson, and G. Warren. 1995b. Reassembly of
Golgi stacks from mitotic Golgi fragments in a cell-free system. J. Cell Biol.
129:605Ð618.
Rabouille, C., H. Kondo, R. Newman, N. Hui, P. Freemont, and G. Warren.
1998. Syntaxin 5 is a common component of the NSF- and p97-mediated re-
assembly pathways of Golgi cisternae from mitotic Golgi fragments in vitro.
Cell. 92:603Ð610.
Robinson, L.J., F. Aniento, and J. Gruenberg. 1997. NSF is required for trans-
port from early to late endosomes. J. Cell Sci. 110:2079Ð2087.
Rodriguez, L., C.J. Stirling, and P.G. Woodman. 1994. Multiple N-ethylmale-
imide-sensitive components are required for endosomal vesicle fusion. Mol.
Biol. Cell. 5:773Ð783.
Rothman, J.E. 1994. Mechanisms of intracellular protein transport. Nature. 372:
55Ð63.
Salpeter, M.M., and M.G. Farquhar. 1981. High resolution analysis of the secre-
tory pathway in mammotrophs of the rat anterior pituitary. J. Cell Biol. 91:
240Ð246.
Smith, R.E., and M.G. Farquhar. 1966. Lysosome function in the regulation of
the secretory process in cells of the anterior pituitary gland. J. Cell Biol. 31:
319Ð347.
Sollner, T., M.K. Bennet, S.W. Whiteheart, R.H. Scheller, and J.E. Rothman.
1993. A protein assembly-disassembly pathway in vitro that may correspond
to sequential steps of synaptic vesicle docking, activation, and fusion. Cell.
75:409Ð418.
Steiner, D.F. 1991. Prohormone convertases revealed at last. Curr. Biol. 1:375Ð377.
Thiele, C., H.H. Gerdes, and W.B. Huttner. 1997. Protein secretion: puzzling
receptors. Curr. Biol. 7:496Ð500.
Tooze, S.A. 1991. Biogenesis of secretory granules Implications arising from
the immature secretory granule in the regulated pathway of secretion. FEBS
(Fed. Eur. Biochem. Soc.) Lett. 285:220Ð224.
Tooze, S.A. 1998. Biogenesis of secretory granules in the trans-Golgi network
of neuroendocrine and endocrine cells. Biochim. Biophys Acta. 1404:231Ð
244.
Tooze, S.A., and W.B. Huttner. 1990. Cell-free protein sorting to the regulated
and constitutive secretory pathways. Cell. 60:837Ð847.
Tooze, S.A., T. Flatmark, J. Tooze, and W.B. Huttner. 1991. Characterization
of the immature secretory granule, an intermediate in granule biogenesis. J.
Cell Biol. 115:1491Ð1503.
Turner, M.D., H. Plutner, and W.E. Balch. 1997. A Rab GTPase is required for
homotypic assembly of the endoplasmic reticulum. J. Biol. Chem. 272:
13479Ð13483.
Urb, S., S. Ditti, and S.A. Tooze. 1997a. pH-dependent processing of secre-
togranin II by the endopeptidase PC2 in isolated immature secretory gran-
ules. Biochem. J. 321:65Ð74.
Urb, S., S.A. Tooze, and F.A. Barr. 1997b. Formation of secretory vesicles in
the biosynthetic pathway. Biochim Biophys Acta. 1358:6Ð22.
Ward, D.M., J.D. Leslie, and J. Kaplan. 1997. Homotypic lysosome fusion inThe Journal of Cell Biology, Volume 143, 1998 1844
macrophages: analysis using an in vitro assay. J. Cell Biol. 139:665Ð673.
Weber, T., B.V. Zemelman, J.A. McNew, B. Westerman, M. Gmachi, F. Par-
lati, T.H. Sllner, and J.E. Rothman. 1998. SNAREpins: minimal machinery
for membrane fusion. Cell. 92:759Ð772.
Weidman, P.J., P. Melancon, M.R. Block, and J.E. Rothman. 1989. Binding of
an N-ethylmaleimideÐsensitive fusion protein to golgi membranes requires
both a soluble protein(s) and an integral membrane protein. J. Cell Biol. 108:
1589Ð1596.
Whiteheart, S.W., I.C. Griff, M. Brunner, D.O. Clary, T. Mayer, S.A. Buhrov,
and J.E. Rothman. 1993. SNAP family of NSF attachment proteins includes
a brain- specific isoform. Nature. 362:353Ð355.
Whiteheart, S.W., and E.W. Kubalek. 1995. SNAPs and NSF: general members
of the fusion apparatus. Trends Cell Biol. 5:64Ð68.
Woodman, P. 1997. The roles of NSF, SNAPs and SNAREs during membrane
fusion. Biochim Biophys Acta. 1357:155Ð172.
Woodman, P.G., and G. Warren. 1988. Fusion between vesicles from the path-
way of receptor-mediated endocytosis in a cell-free system. Eur. J. Biochem.
173:101Ð108.